{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:07:24Z","timestamp":1794276444251,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82071109"],"award-info":[{"award-number":["82071109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yuansong Academician Expert Workstation Grants","award":["19R1002275468"],"award-info":[{"award-number":["19R1002275468"]}]},{"name":"Yuansong Academician Expert Workstation Grants","award":["20R9004076411"],"award-info":[{"award-number":["20R9004076411"]}]},{"name":"Yuansong Academician Expert Workstation Grants","award":["21R4007547098"],"award-info":[{"award-number":["21R4007547098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic administration of oncolytic adenovirus for cancer therapy is still a challenge. Mesenchymal stem cells as cell carriers have gained increasing attention in drug delivery due to their excellent tumor tropism, immunosuppressive modulatory effects, and paracrine effects. However, the potential of human dental pulp stem cells (hDPSCs) loaded with oncolytic adenovirus for cancer biotherapy has not been investigated yet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The stemness of hDPSCs was characterized by FACS analysis and Alizarin red staining, Oil Red O staining, and immunofluorescence assays. The biological fitness of hDPSCs loaded with oncolytic adenovirus YSCH-01 was confirmed by virus infection with different dosages and cell viability CCK-8 assays. Additionally, the expression of CAR receptor in hDPSCs was detected by qPCR assay. Tumor tropism of hDPSC loaded with YSCH-01 in vitro and in vivo was investigated by Transwell assays and living tumor-bearing mice imaging technology and immunohistochemistry, Panoramic scanning of frozen section slices assay analysis. Furthermore, the antitumor efficacy was observed through the different routes of YSCH-01\/hPDSCs administration in SW780 and SCC152 xenograft models. The direct tumor cell-killing effect of YSCH-01\/hDPSCs in the co-culture system was studied, and the supernatant of YSCH-01\/hDPSCs inhibited cell growth was further analyzed by CCK-8 assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>hDPSCs were found to be susceptible to infection by a novel oncolytic adenovirus named YSCH-01 and were capable of transporting this virus to tumor sites at 1000 VP\/cell infectious dosage in vitro and in vivo. Moreover, it was discovered that intraperitoneal injection of hDPSCs loaded with oncolytic adenovirus YSCH-01 exhibited potential anti-tumor effects in both SW780 and SCC152 xenograft models. The crucial role played by the supernatant secretome derived from hDPSCs loaded with YSCH-01 significantly exerted a specific anti-tumor effect without toxicity for normal cells, in both an active oncolytic virus and an exogenous protein-independent manner. Furthermore, the use of hDPSCs as a cell carrier significantly reduced the required dosage of virus delivery in vivo compared to other methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings highlight the promising clinical potential of hDPSCs as a novel cell carrier in the field of oncolytic virus-based anti-cancer therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04539-z","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T06:02:21Z","timestamp":1696312941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus"],"prefix":"10.1186","volume":"21","author":[{"given":"Xu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ding","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"2","key":"4539_CR1","doi-asserted-by":"publisher","first-page":"e001486","DOI":"10.1136\/jitc-2020-001486","volume":"8","author":"N Macedo","year":"2020","unstructured":"Macedo N, Miller DM, Haq R, Kaufman HL. Clinical landscape of oncolytic virus research in 2020. J Immunother Cancer. 2020;8(2):e001486. https:\/\/doi.org\/10.1136\/jitc-2020-001486.","journal-title":"J Immunother Cancer"},{"key":"4539_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","volume":"9","author":"R Ma","year":"2023","unstructured":"Ma R, Li Z, Chiocca EA, Caligiuri MA, Yu J. The emerging field of oncolytic virus-based cancer immunotherapy. Trends in Cancer. 2023;9:122\u201339.","journal-title":"Trends in Cancer"},{"key":"4539_CR3","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1080\/21645515.2020.1723363","volume":"16","author":"M Mondal","year":"2020","unstructured":"Mondal M, Guo J, He P, Zhou D. Recent advances of oncolytic virus in cancer therapy. Hum Vaccin Immunother. 2020;16:2389\u2013402.","journal-title":"Hum Vaccin Immunother"},{"key":"4539_CR4","doi-asserted-by":"publisher","first-page":"197675","DOI":"10.1016\/j.virusres.2019.197675","volume":"270","author":"LQ Fu","year":"2019","unstructured":"Fu LQ, Wang SB, Cai MH, Wang XJ, Chen JY, Tong XM, Chen XY, Mou XZ. Recent advances in oncolytic virus-based cancer therapy. Virus Res. 2019;270:197675.","journal-title":"Virus Res"},{"issue":"571","key":"4539_CR5","doi-asserted-by":"publisher","first-page":"eabc6659","DOI":"10.1126\/scitranslmed.abc6659","volume":"12","author":"S Atasheva","year":"2020","unstructured":"Atasheva S, Emerson CC, Yao J, Young C, Stewart PL, Shayakhmetov DM. Systemic cancer therapy with engineered adenovirus that evades innate immunity. Sci Transl Med. 2020;12(571):eabc6659. https:\/\/doi.org\/10.1126\/scitranslmed.abc6659.","journal-title":"Sci Transl Med"},{"key":"4539_CR6","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.1021\/acsnano.6b06182","volume":"10","author":"J Chen","year":"2016","unstructured":"Chen J, Gao P, Yuan S, Li R, Ni A, Chu L, Ding L, Sun Y, Liu XY, Duan Y. Oncolytic adenovirus complexes coated with lipids and calcium phosphate for cancer gene therapy. ACS Nano. 2016;10:11548\u201360.","journal-title":"ACS Nano"},{"key":"4539_CR7","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1039\/D0BM00681E","volume":"8","author":"H Kong","year":"2020","unstructured":"Kong H, Zhao R, Zhang Q, Iqbal MZ, Lu J, Zhao Q, Luo D, Feng C, Zhang K, Liu X, Kong X. Biosilicified oncolytic adenovirus for cancer viral gene therapy. Biomater Sci. 2020;8:5317\u201328.","journal-title":"Biomater Sci"},{"key":"4539_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.18632\/oncotarget.27401","volume":"11","author":"L Franco-Luzon","year":"2020","unstructured":"Franco-Luzon L, Gonzalez-Murillo A, Alcantara-Sanchez C, Garcia-Garcia L, Tabasi M, Huertas AL, Chesler L, Ramirez M. Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma. Oncotarget. 2020;11:347\u201361.","journal-title":"Oncotarget"},{"key":"4539_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41598-019-57240-x","volume":"10","author":"KJ Mahasa","year":"2020","unstructured":"Mahasa KJ, de Pillis L, Ouifki R, Eladdadi A, Maini P, Yoon AR, Yun CO. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy. Sci Rep. 2020;10:425.","journal-title":"Sci Rep"},{"key":"4539_CR10","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.3390\/v7122921","volume":"7","author":"J Kim","year":"2015","unstructured":"Kim J, Hall RR, Lesniak MS, Ahmed AU. Stem cell-based cell carrier for targeted oncolytic virotherapy: translational opportunity and open questions. Viruses. 2015;7:6200\u201317.","journal-title":"Viruses"},{"key":"4539_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12964-022-01012-0","volume":"21","author":"N Ghasemi Darestani","year":"2023","unstructured":"Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, et al. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21:43.","journal-title":"Cell Commun Signal"},{"key":"4539_CR12","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1158\/0008-5472.CAN-18-3900","volume":"79","author":"AR Yoon","year":"2019","unstructured":"Yoon AR, Hong J, Li Y, Shin HC, Lee H, Kim HS, Yun CO. Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma. Cancer Res. 2019;79:4503\u201314.","journal-title":"Cancer Res"},{"key":"4539_CR13","doi-asserted-by":"publisher","first-page":"dju090","DOI":"10.1093\/jnci\/dju090","volume":"106","author":"M Duebgen","year":"2014","unstructured":"Duebgen M, Martinez-Quintanilla J, Tamura K, Hingtgen S, Redjal N, Wakimoto H, Shah K. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. J Natl Cancer Inst. 2014;106:dju090.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4539_CR14","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/cells8121491","volume":"8","author":"M De la Rosa-Ruiz","year":"2019","unstructured":"De la Rosa-Ruiz M, \u00c1lvarez-P\u00e9rez M, Cort\u00e9s-Morales V, Monroy-Garc\u00eda A, Mayani H, Fragoso-Gonz\u00e1lez G, Caballero-Chac\u00f3n S, Diaz D, Candanedo-Gonz\u00e1lez F, Montesinos J. Mesenchymal stem\/stromal cells derived from dental tissues: a comparative in vitro evaluation of their immunoregulatory properties against T cells. Cells. 2019;8(12):1491. https:\/\/doi.org\/10.3390\/cells8121491.","journal-title":"Cells"},{"key":"4539_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12013-013-9632-6","volume":"67","author":"W Chen","year":"2013","unstructured":"Chen W, Li M, Cheng H, Yan Z, Cao J, Pan B, Sang W, Wu Q, Zeng L, Li Z, Xu K. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells. Cell Biochem Biophys. 2013;67:1181\u201391.","journal-title":"Cell Biochem Biophys"},{"key":"4539_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s12015-021-10159-1","volume":"17","author":"G Merckx","year":"2021","unstructured":"Merckx G, Lo Monaco M, Lambrichts I, Himmelreich U, Bronckaers A, Wolfs E. Safety and homing of human dental pulp stromal cells in head and neck cancer. Stem Cell Rev Rep. 2021;17:1619\u201334.","journal-title":"Stem Cell Rev Rep"},{"key":"4539_CR17","doi-asserted-by":"publisher","first-page":"13625","DOI":"10.1073\/pnas.240309797","volume":"97","author":"S Gronthos","year":"2000","unstructured":"Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000;97:13625\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4539_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12860-017-0128-x","volume":"18","author":"A Alraies","year":"2017","unstructured":"Alraies A, Alaidaroos NY, Waddington RJ, Moseley R, Sloan AJ. Variation in human dental pulp stem cell ageing profiles reflect contrasting proliferative and regenerative capabilities. BMC Cell Biol. 2017;18:12.","journal-title":"BMC Cell Biol"},{"key":"4539_CR19","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1089\/ten.2006.12.2813","volume":"12","author":"W Zhang","year":"2006","unstructured":"Zhang W, Walboomers XF, Shi S, Fan M, Jansen JA. Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng. 2006;12:2813\u201323.","journal-title":"Tissue Eng"},{"key":"4539_CR20","doi-asserted-by":"publisher","first-page":"101766","DOI":"10.1016\/j.tice.2022.101766","volume":"76","author":"L Liu","year":"2022","unstructured":"Liu L, Xie H, Zhao S, Huang X. The GLUT1-mTORC1 axis affects odontogenic differentiation of human dental pulp stem cells. Tissue Cell. 2022;76:101766.","journal-title":"Tissue Cell"},{"key":"4539_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/cbin.10056","volume":"37","author":"S Balasubramanian","year":"2013","unstructured":"Balasubramanian S, Thej C, Venugopal P, Priya N, Zakaria Z, Sundarraj S, Majumdar AS. Higher propensity of Wharton\u2019s jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow. Cell Biol Int. 2013;37:507\u201315.","journal-title":"Cell Biol Int"},{"key":"4539_CR22","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/ncomms6513","volume":"5","author":"Q Fang","year":"2014","unstructured":"Fang Q, Inanc B, Schamus S, Wang XH, Wei L, Brown AR, Svilar D, Sugrue KF, Goellner EM, Zeng X, et al. HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase beta. Nat Commun. 2014;5:5513.","journal-title":"Nat Commun"},{"key":"4539_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1423-0127-19-20","volume":"19","author":"KJ Zhang","year":"2012","unstructured":"Zhang KJ, Qian J, Wang SB, Yang Y. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma. J Biomed Sci. 2012;19:20.","journal-title":"J Biomed Sci"},{"key":"4539_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/scd.2009.0177","volume":"19","author":"U Nekanti","year":"2010","unstructured":"Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M. Long-term expansion and pluripotent marker array analysis of Wharton\u2019s jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010;19:117\u201330.","journal-title":"Stem Cells Dev"},{"key":"4539_CR25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/1078-0432.CCR-16-1386","volume":"23","author":"KJ Zhang","year":"2017","unstructured":"Zhang KJ, Yin XF, Yang YQ, Li HL, Xu YN, Chen LY, Liu XJ, Yuan SJ, Fang XL, Xiao J, et al. A Potent in vivo antitumor efficacy of novel recombinant type I interferon. Clin Cancer Res. 2017;23:2038\u201349.","journal-title":"Clin Cancer Res"},{"key":"4539_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2018.04.213","volume":"501","author":"R Kunimatsu","year":"2018","unstructured":"Kunimatsu R, Nakajima K, Awada T, Tsuka Y, Abe T, Ando K, Hiraki T, Kimura A, Tanimoto K. Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2018;501:193\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"4539_CR27","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1096\/fj.201902482R","volume":"34","author":"P Pagella","year":"2020","unstructured":"Pagella P, Miran S, Neto E, Martin I, Lamghari M, Mitsiadis TA. Human dental pulp stem cells exhibit enhanced properties in comparison to human bone marrow stem cells on neurites outgrowth. FASEB J. 2020;34:5499\u2013511.","journal-title":"FASEB J"},{"key":"4539_CR28","doi-asserted-by":"publisher","first-page":"e109305","DOI":"10.1371\/journal.pone.0109305","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead B, Logan A, Berry M, Leadbeater W, Scheven BA. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS ONE. 2014;9:e109305.","journal-title":"PLoS ONE"},{"key":"4539_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1743-422X-7-148","volume":"7","author":"C Lyle","year":"2010","unstructured":"Lyle C, McCormick F. Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells. Virol J. 2010;7:148.","journal-title":"Virol J"},{"key":"4539_CR30","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/emboj\/16.9.2294","volume":"16","author":"SS Hong","year":"1997","unstructured":"Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997;16:2294\u2013306.","journal-title":"EMBO J"},{"key":"4539_CR31","doi-asserted-by":"publisher","first-page":"e1006914","DOI":"10.1371\/journal.ppat.1006914","volume":"14","author":"N Stichling","year":"2018","unstructured":"Stichling N, Suomalainen M, Flatt JW, Schmid M, Pacesa M, Hemmi S, Jungraithmayr W, Maler MD, Freudenberg MA, Pluckthun A, et al. Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor. PLoS Pathog. 2018;14:e1006914.","journal-title":"PLoS Pathog"},{"key":"4539_CR32","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s12015-021-10255-2","volume":"18","author":"M Bousnaki","year":"2022","unstructured":"Bousnaki M, Bakopoulou A, Pich A, Papachristou E, Kritis A, Koidis P. Mapping the secretome of dental pulp stem cells under variable microenvironmental conditions. Stem Cell Rev Rep. 2022;18:1372\u2013407.","journal-title":"Stem Cell Rev Rep"},{"key":"4539_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","volume":"77","author":"D Furlani","year":"2009","unstructured":"Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77:370\u20136.","journal-title":"Microvasc Res"},{"key":"4539_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/sctm.18-0024","volume":"7","author":"TEG Krueger","year":"2018","unstructured":"Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN. Concise review: mesenchymal stem cell-based drug delivery: the good, the bad, the ugly, and the promise. Stem Cells Transl Med. 2018;7:651\u201363.","journal-title":"Stem Cells Transl Med"},{"key":"4539_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/stem.1271","volume":"31","author":"J Nystedt","year":"2013","unstructured":"Nystedt J, Anderson H, Tikkanen J, Pietila M, Hirvonen T, Takalo R, Heiskanen A, Satomaa T, Natunen S, Lehtonen S, et al. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells. Stem Cells. 2013;31:317\u201326.","journal-title":"Stem Cells"},{"key":"4539_CR36","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009;27:2614\u201323.","journal-title":"Stem Cells"},{"key":"4539_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbrc.2014.07.074","volume":"451","author":"Y Peng","year":"2014","unstructured":"Peng Y, Li Z, Yang P, Newton IP, Ren H, Zhang L, Wu H, Li Z. Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts. Biochem Biophys Res Commun. 2014;451:68\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"4539_CR38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.81","volume":"27","author":"H Wang","year":"2009","unstructured":"Wang H, Cao F, De A, Cao Y, Contag C, Gambhir SS, Wu JC, Chen X. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells. 2009;27:1548\u201358.","journal-title":"Stem Cells"},{"key":"4539_CR39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.stemcr.2017.04.009","volume":"8","author":"KM Piltti","year":"2017","unstructured":"Piltti KM, Funes GM, Avakian SN, Salibian AA, Huang KI, Carta K, Kamei N, Flanagan LA, Monuki ES, Uchida N, et al. Increasing human neural stem cell transplantation dose alters oligodendroglial and neuronal differentiation after spinal cord injury. Stem Cell Reports. 2017;8:1534\u201348.","journal-title":"Stem Cell Reports"},{"key":"4539_CR40","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ijc.25440","volume":"127","author":"K Shinagawa","year":"2010","unstructured":"Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, Tanaka S, Yasui W, Chayama K. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer. 2010;127:2323\u201333.","journal-title":"Int J Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04539-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04539-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04539-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T02:31:00Z","timestamp":1700533860000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04539-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4539"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04539-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study was approved by the institutional Ethics Committee (IACUC), Shanghai LideBiotech Co., Ltd (LDIACUC 006).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Kang-Jian Zhang holds an ownership interest (including patents of YSCH-01) in Yuansong Biotechnology Limited Company, while Xin-Yuan Liu is a board member of Yuansong Biotechnology Co., Ltd. No potential conflicts of interest were disclosed by the other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"688"}}